Payment overview · 2025
General Payments
$121.84
1 reported records · 1 companies
Healthcare provider profile · identity verified
Daniel Lee Thorngren, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · SAFETY HARBOR, FL · NPI 1033537105
Verified facts
What the public records show
CMS Open Payments records show Daniel Lee Thorngren, M.D. received $121.84 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Nuedexta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $121.84 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $121.84 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $121.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
20 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 730 | 178 |
| Eliquis | Apixaban | 530 | 102 |
| Gabapentin | Gabapentin | 491 | 119 |
| Amlodipine Besylate | Amlodipine Besylate | 403 | 100 |
| Trazodone Hcl | Trazodone Hcl | 393 | 106 |
| Divalproex Sodium | Divalproex Sodium | 341 | 79 |
| Metformin Hcl | Metformin Hcl | 329 | 64 |
| Levothyroxine Sodium | Levothyroxine Sodium | 316 | 81 |
| Furosemide | Furosemide | 270 | 78 |
| Tamsulosin Hcl | Tamsulosin Hcl | 243 | 64 |
| Lisinopril | Lisinopril | 233 | 67 |
| Losartan Potassium | Losartan Potassium | 223 | 65 |
| Metoprolol Tartrate | Metoprolol Tartrate | 217 | 66 |
| Pantoprazole Sodium | Pantoprazole Sodium | 215 | 68 |
| Duloxetine Hcl | Duloxetine Hcl | 188 | 37 |
| Donepezil Hcl | Donepezil Hcl | 186 | 47 |
| Potassium Chloride | Potassium Chloride | 186 | 61 |
| Clopidogrel | Clopidogrel Bisulfate | 164 | 38 |
| Escitalopram Oxalate | Escitalopram Oxalate | 158 | 45 |
| Quetiapine Fumarate | Quetiapine Fumarate | 144 | 45 |
| Levetiracetam | Levetiracetam | 139 | 41 |
| Metoprolol Succinate | Metoprolol Succinate | 139 | 46 |
| Sertraline Hcl | Sertraline Hcl | 138 | 50 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 135 | 30 |
| Memantine Hcl | Memantine Hcl | 132 | 35 |
| Mirtazapine | Mirtazapine | 130 | 44 |
| Carvedilol | Carvedilol | 126 | 49 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 114 | 25 |
| Buspirone Hcl | Buspirone Hcl | 109 | 34 |
| Fluoxetine Hcl | Fluoxetine Hcl | 105 | 28 |
| Risperidone | Risperidone | 105 | 30 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 102 | 34 |
| Ondansetron Hcl | Ondansetron Hcl | 97 | 46 |
| Montelukast Sodium | Montelukast Sodium | 95 | 25 |
| Baclofen | Baclofen | 93 | 24 |
| Lactulose | Lactulose | 93 | 35 |
| Oxycodone Hcl | Oxycodone Hcl | 88 | 27 |
| Prednisone | Prednisone | 88 | 34 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 87 | 49 |
| Xarelto | Rivaroxaban | 87 | 14 |
| Olanzapine | Olanzapine | 84 | 25 |
| Jardiance | Empagliflozin | 78 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 76 | 12 |
| Lamotrigine | Lamotrigine | 75 | 14 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 74 | 21 |
| Sucralfate | Sucralfate | 74 | 22 |
| Spironolactone | Spironolactone | 72 | 24 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 71 | 14 |
| Simvastatin | Simvastatin | 71 | 16 |
| Tramadol Hcl | Tramadol Hcl | 71 | 23 |
| Trulicity | Dulaglutide | 70 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 66 | 19 |
| Doxycycline Hyclate | Doxycycline Hyclate | 65 | 41 |
| Ketoconazole | Ketoconazole | 64 | 21 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 61 | 31 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 60 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 59 | 42 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 59 | 15 |
| Nystatin | Nystatin | 58 | 34 |
| Hydralazine Hcl | Hydralazine Hcl | 57 | 24 |
| Benztropine Mesylate | Benztropine Mesylate | 56 | 14 |
| Warfarin Sodium | Warfarin Sodium | 55 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 54 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 52 | 27 |
| Bumetanide | Bumetanide | 51 | 18 |
| Clonazepam | Clonazepam | 50 | 22 |
| Silver Sulfadiazine | Silver Sulfadiazine | 50 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 50 | 28 |
| Atenolol | Atenolol | 49 | suppressed |
| Cephalexin | Cephalexin | 47 | 27 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 47 | 32 |
| Midodrine Hcl | Midodrine Hcl | 47 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 47 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 46 | 21 |
| Lorazepam | Lorazepam | 46 | 30 |
| Nifedipine Er | Nifedipine | 45 | 13 |
| Topiramate | Topiramate | 45 | 13 |
| Chlorthalidone | Chlorthalidone | 43 | suppressed |
| Omeprazole | Omeprazole | 43 | 18 |
| Haloperidol | Haloperidol | 40 | 14 |
| Oxcarbazepine | Oxcarbazepine | 40 | 16 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 40 | 26 |
| Breo Ellipta | Fluticasone/Vilanterol | 39 | 12 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 39 | 17 |
| Finasteride | Finasteride | 38 | 13 |
| Latanoprost | Latanoprost | 38 | 13 |
| Allopurinol | Allopurinol | 37 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 36 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 36 | suppressed |
| Azithromycin | Azithromycin | 35 | 21 |
| Dapagliflozin | Dapagliflozin Propanediol | 35 | 16 |
| Incruse Ellipta | Umeclidinium Bromide | 35 | 11 |
| Novolog Flexpen | Insulin Aspart | 35 | 14 |
| Clozapine | Clozapine | 34 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 34 | 16 |
| Ceftriaxone | Ceftriaxone Sodium | 33 | 21 |
| Meloxicam | Meloxicam | 33 | 15 |
| Permethrin | Permethrin | 32 | 19 |
| Ibuprofen | Ibuprofen | 31 | suppressed |
| Methocarbamol | Methocarbamol | 31 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 31 | suppressed |
| Ezetimibe | Ezetimibe | 30 | suppressed |
| Myrbetriq | Mirabegron | 30 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 30 | suppressed |
| Alprazolam | Alprazolam | 29 | 15 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 29 | 16 |
| Alendronate Sodium | Alendronate Sodium | 28 | 12 |
| Carbamazepine | Carbamazepine | 27 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 27 | 15 |
| Metformin Hcl Er | Metformin Hcl | 27 | suppressed |
| Bupropion Xl | Bupropion Hcl | 26 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 26 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 22 |
| Cefdinir | Cefdinir | 24 | 18 |
| Ventolin Hfa | Albuterol Sulfate | 24 | 15 |
| Albuterol Sulfate | Albuterol Sulfate | 23 | 16 |
| Clobetasol Propionate | Clobetasol Propionate | 23 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 23 | suppressed |
| Januvia | Sitagliptin Phosphate | 23 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 23 | 19 |
| Ondansetron Odt | Ondansetron | 23 | 11 |
| Acetazolamide | Acetazolamide | 22 | suppressed |
| Aripiprazole | Aripiprazole | 22 | suppressed |
| Primidone | Primidone | 22 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 21 | 11 |
| Clonidine Hcl | Clonidine Hcl | 21 | 12 |
| Epogen | Epoetin Alfa | 21 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 21 | 11 |
| Lovastatin | Lovastatin | 21 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 20 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 20 | suppressed |
| Levofloxacin | Levofloxacin | 20 | 12 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 20 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 20 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 20 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 20 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 19 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 19 | 14 |
| Calcitriol | Calcitriol | 19 | suppressed |
| Clonidine | Clonidine | 19 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 19 | suppressed |
| Ertapenem | Ertapenem Sodium | 19 | 14 |
| Movantik | Naloxegol Oxalate | 19 | suppressed |
| Mupirocin | Mupirocin | 19 | 17 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Cilostazol | Cilostazol | 18 | suppressed |
| Fentanyl | Fentanyl | 18 | suppressed |
| Fluconazole | Fluconazole | 18 | 13 |
| Pentoxifylline | Pentoxifylline | 18 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 18 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 18 | suppressed |
| Celecoxib | Celecoxib | 17 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 17 | suppressed |
| Glipizide | Glipizide | 17 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Brilinta | Ticagrelor | 16 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 16 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 16 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 16 | suppressed |
| Minoxidil | Minoxidil | 16 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 16 | 14 |
| Nystop | Nystatin | 16 | 13 |
| Propafenone Hcl | Propafenone Hcl | 16 | suppressed |
| Admelog Solostar | Insulin Lispro | 15 | suppressed |
| Asenapine Maleate | Asenapine Maleate | 15 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 15 | 11 |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 15 | suppressed |
| Dexamethasone | Dexamethasone | 15 | suppressed |
| Estradiol | Estradiol | 15 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 15 | suppressed |
| Lacosamide | Lacosamide | 15 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 15 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 15 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Timolol Maleate | Timolol Maleate | 15 | suppressed |
| Alosetron Hcl | Alosetron Hcl | 14 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Cyclosporine | Cyclosporine | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 14 | suppressed |
| Insulin Lispro | Insulin Lispro | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Ivermectin | Ivermectin | 14 | suppressed |
| Phenobarbital | Phenobarbital | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Zonisamide | Zonisamide | 14 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 13 | 13 |
| Carbamazepine Er | Carbamazepine | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Glucagon Emergency Kit | Glucagon | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Levemir Flexpen | Insulin Detemir | 13 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Briviact | Brivaracetam | 12 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 11 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 11 | suppressed |
| Klor-Con 10 | Potassium Chloride | 11 | suppressed |
| Levetiracetam Er | Levetiracetam | 11 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 11 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 11 | suppressed |
| Pregabalin | Pregabalin | 11 | suppressed |
| Retacrit | Epoetin Alfa-Epbx | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $121.84 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error